查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988291

微創手術市場：按設備類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

Minimally Invasive Surgery Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，微創手術市場價值將達到 918.6 億美元，到 2026 年將成長至 1,037.2 億美元，到 2032 年將達到 2,220 億美元，年複合成長率為 13.43%。

主要市場統計數據
基準年 2025 918.6億美元
預計年份：2026年 1037.2億美元
預測年份 2032 2220億美元
複合年成長率 (%) 13.43%

微創手術模式轉移中不斷發展的臨床實踐和技術突破的舞台。

在技​​術突破和臨床通訊協定不斷改進的推動下，微創外科領域經歷了快速變革。外科醫師、醫療機構和醫療設備製造商通用攜手合作，致力於提高手術精準度，同時減輕病患負擔。隨著臨床醫生從傳統開放性手術轉向內視鏡手術，他們開始採用內視鏡、先進的能量傳輸系統和高清視訊平台，以最佳化視野和操控。在此背景下，患者對更快康復的需求日益成長、醫療預算緊張以及醫院患者容量壓力不斷增加等因素，正加速微創手術在全球範圍內的普及。

揭示將重塑微創手術臨床結果、醫療服務模式和醫療設備創新的變革性變化。

影像技術、儀器設計和手術流程的創新開啟了微創調查方法的新時代，有望帶來更高的精準度和更佳的患者預後。多光譜內頻譜和先進能量儀器的普及突破了傳統手術的限制，使醫生能夠進入解剖結構複雜且以往難以觸及的區域。同時，即時數據疊加和擴增實境（AR）平台的整合增強了外科醫生的術中情境察覺，提高了手術安全性，並減少了對試驗試驗的依賴。

評估美國將於 2025 年前實施的貿易關稅政策對微創外科手術解決方案累積影響。

到了2025年，美國貿易關稅的累積影響為微創手術器械的供應鏈帶來新的複雜性。先進內視鏡、能量產生器和機器人模組等零件的進口關稅推高了依賴全球採購網路的製造商的成本。雖然一些公司已自行承擔了部分額外成本以維持價格競爭力，但整個生態系統都面臨著採購週期延長和供應商協議重新談判的壓力。

從設備類型、技術、應用和最終用戶細分中獲得關鍵見解，以推動 MIS 中的策略決策。

市場區隔分析顯示，以內視鏡、能量器材、腹腔鏡器材和視訊平台為核心的設備組合，各自展現出獨特的成長要素。在腹腔鏡器械領域，材料科學和人體工學的穩定發展體現在分離器、格拉帕鉗、牽開器、剪刀和套管針等器械中，從而提升了外科醫生的舒適度和手術效率。隨著這些器械不斷適應日益複雜的手術情況，它們與先進成像和能量供應系統的整合，進一步凸顯了硬體設計與臨床工作流程之間至關重要的相互關係。

分析美洲、歐洲、中東和非洲以及亞太地區微創手術普及程度的區域差異和成長要素。

微創手術的區域趨勢反映了不同地區在採用率上的差異，而這種差異受到醫療基礎設施、報銷模式和人口趨勢的影響。在美洲，對醫院維修和門診設施擴建的大力投資正在推動先進平台的快速普及。此外，向價值醫療模式的轉變鼓勵採用能夠縮短住院時間和最大限度減少術後併發症的治療方法，從而進一步提升了對微創手術的需求。

分析微創手術領域主要企業的策略性舉措、技術合作和競爭地位。

微創手術領域的主要企業採取多元化策略，以鞏固市場地位並加速創新。全球醫療設備製造商正在部署跨平台整合解決方案，將影像、能量照射和導航功能結合，旨在提供能夠改善外科醫生工作流程的綜合手術室。透過策略收購機器人專家和能量設備創新者，這些企業正在強化其產品藍圖；同時，與學術機構的合作正在加速早期療效檢驗和外科醫生培訓計畫的發展。

為行業領導者提供切實可行的建議，以克服監管挑戰、加速創新並最佳化進入 MIS 市場。

為了應對瞬息萬變的環境，產業領導者應優先與監管機構合作，加速新醫療設備的核准流程，同時確保嚴格的安全標準。建立專門團隊與監管機構合作，可簡化臨床試驗設計，加速產品上市。同時，與支付方合作建構基於價值的報銷機制，將增強微創手術的經濟獎勵，並促進醫療服務提供者更廣泛地接受微創手術。

對 MIS 報告中為確保全面分析和可靠見解而採用的嚴謹、多方面的調查方法說明。

本報告整合了嚴謹的多層次調查方法所得出的洞見，旨在捕捉宏觀趨勢和特定產業的細微差別。主要研究包括對關鍵決策者（KOL）的深度訪談，其中包括門診手術中心和醫院的終端使用者、採購負責人以及臨床KOL。這些一線觀點為新興醫療設備偏好和手術流程提供了至關重要的檢驗。

對微創手術實踐中的關鍵趨勢、策略挑戰和未來前景進行綜合分析，得出全面的結論。

總之，微創手術領域正處於技術創新與不斷變化的醫療需求的交會點。從內視鏡和能量傳輸系統到腹腔鏡器械和影像設備，醫療設備的創新不斷突破手術的可能性，而機器人輔助手術則不斷拓展人體工學和精準度的邊界。同時，價格壓力和區域差異凸顯了製定前瞻性供應鏈策略和立足本地市場的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 微創手術市場：依器械類型分類

  • 內視鏡
  • 能源設備
  • 腹腔鏡器械
    • 分離器
    • 夾爪
    • 牽開器
    • 剪刀
    • 套管針
  • 影像設備

第9章 微創手術市場：依技術分類

  • 手動的
  • 機器人輔助
    • 多臂機器人
    • 單臂機器人

第10章 微創手術市場：依應用領域分類

  • 循環系統
  • 一般外科
  • 婦科
  • 泌尿系統

第11章 微創手術市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 初級保健
    • 二級醫療保健
    • 三級醫療保健

第12章 微創手術市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 微創手術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 微創手術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國微創手術市場

第16章 中國微創手術市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Arthrex, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Conmed Corporation
  • Cook Group Incorporated by The Cooper Companies, Inc.
  • Danaher Corporation
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hoya Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Koninklijke Philips NV
  • Livanova PLC
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Synaptive Medical Inc.
  • Teleflex Incorporated
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-7A22CB0E591C

The Minimally Invasive Surgery Market was valued at USD 91.86 billion in 2025 and is projected to grow to USD 103.72 billion in 2026, with a CAGR of 13.43%, reaching USD 222.00 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 91.86 billion
Estimated Year [2026] USD 103.72 billion
Forecast Year [2032] USD 222.00 billion
CAGR (%) 13.43%

Setting the Stage for Evolving Clinical Practices and Technological Breakthroughs in the Changing Paradigm of Minimally Invasive Surgery

The landscape of minimally invasive surgery has undergone a rapid transformation driven by technological breakthroughs and evolving clinical protocols. Surgeons, healthcare institutions, and medical device manufacturers now converge around a shared goal of reducing patient trauma while enhancing procedural precision. As traditional open procedures give way to keyhole interventions, clinicians have embraced endoscopes, advanced energy delivery systems, and high-definition video platforms to optimize visualization and control. Against this backdrop, a confluence of factors-rising patient preference for faster recovery, tightening healthcare budgets, and mounting pressure on hospital throughput-has accelerated the adoption of minimally invasive approaches worldwide.

Moreover, the convergence of digital innovation and surgical technique has redefined the operating room. Cloud-based data analytics, AI-driven image guidance, and telecollaboration tools have enhanced preoperative planning and intraoperative decision making. Concurrently, educational institutions and professional societies have prioritized simulation-based training and credentialing programs to equip the next generation of surgeons with the skills required for complex minimally invasive procedures. Together, these dynamics have reshaped care pathways, elevating patient satisfaction, reducing length of stay, and creating a fertile ground for continued innovation across devices, robotics, and software ecosystems.

Unveiling the Transformative Shifts Reshaping Clinical Outcomes, Healthcare Delivery Models, and Device Innovation in Minimally Invasive Surgery

Innovations in imaging modalities, instrument design, and procedural workflows have ushered in a new era of minimally invasive methodologies that promise greater precision and improved patient outcomes. The proliferation of multi-spectrum endoscopes and advanced energy devices has transcended traditional barriers, enabling access to anatomically complex and previously unreachable regions. In parallel, the integration of real-time data overlays and augmented reality platforms has bolstered surgeons' situational awareness, fostering safer interventions and reducing reliance on trial-and-error techniques.

Furthermore, the rise of robotic-assisted platforms marks a transformative shift in how surgical teams collaborate and execute intricate procedures. Multiarm systems deliver enhanced dexterity and tremor filtration, allowing for micro-precision that surpasses human steadiness. At the same time, singlearm robotic modules are democratizing access by offering cost-efficient solutions for community hospitals and outpatient settings. This dual approach to automation underscores a broader trend toward modular, interoperable systems that can adapt to diverse case types across cardiovascular, gynecological, urological, and general surgical specialties.

Assessing the Cumulative Impact of U.S. Trade Tariff Policies Implemented by 2025 on the Adoption of Minimally Invasive Surgical Solutions

The cumulative effect of U.S. trade tariffs implemented by 2025 has introduced new complexities into the supply chain for minimally invasive surgical equipment. Import duties on components for advanced endoscopes, energy-based generators, and robotic modules have elevated costs for manufacturers relying on global sourcing networks. Although some companies have absorbed a portion of these additional expenses to maintain competitive pricing, the broader ecosystem has felt pressure through elongated procurement cycles and renegotiated vendor agreements.

Consequently, healthcare providers have recalibrated purchasing strategies to mitigate cost increases. Some institutions have prioritized domestically produced instruments, while others have sought long-term contracts to lock in pricing and guarantee supply continuity. Despite these headwinds, the drive toward procedural efficiency and clinical efficacy remains undiminished. As a result, manufacturers are exploring strategic partnerships and alternative component suppliers to navigate tariff-induced margins and preserve the trajectory of minimally invasive innovation.

Revealing Key Insights from Device Type, Technology, Application and End User Segmentation to Drive Strategic Decision-Making in MIS

Analysis of market segmentation reveals that device portfolios centered on endoscopes, energy devices, laparoscopic instruments, and video platforms each exhibit unique growth catalysts. Within the laparoscopic instruments category, instruments such as dissectors, graspers, retractors, scissors, and trocars demonstrate steady evolution in material science and ergonomics, enhancing both surgeon comfort and procedural efficiency. As these tools adapt to increasingly complex case mixes, their integration with advanced imaging and energy delivery systems further underscores the critical interplay between hardware design and clinical workflow.

Segmentation by technology highlights the contrast between manual approaches and robotic-assisted ecosystems. Manual instruments continue to benefit from incremental improvements in user interface and haptic feedback, supporting high-volume ambulatory surgery center procedures. Meanwhile, robotic-assisted solutions-spanning both multiarm and singlearm configurations-are enabling greater procedural versatility, particularly in intricate cardiovascular, gynecological, and urological interventions. Application-based insights underscore strong uptake in general surgery contexts, where standardization of protocols accelerates adoption, complemented by growing interest in niche procedures across oncology and endocrine specialties. Finally, understanding the end user landscape reveals that ambulatory surgery centers focus on high-throughput, cost-effective procedures, while hospitals across primary, secondary, and tertiary care tiers demand comprehensive systems capable of supporting complex case portfolios and integrated care pathways.

Highlighting Regional Variations and Growth Drivers Across the Americas, Europe Middle East Africa, and Asia Pacific in Minimally Invasive Surgery Adoption

Regional dynamics in minimally invasive surgery reflect disparate adoption rates influenced by healthcare infrastructure, reimbursement models, and demographic trends. In the Americas, robust capital investment in hospital renovation and outpatient facility expansion has underpinned strong uptake of advanced platforms. Additionally, policy shifts aimed at value-based care have incentivized interventions that reduce length of stay and minimize postoperative complications, further fueling demand for minimally invasive procedures.

Meanwhile, Europe, the Middle East and Africa exhibit heterogeneous growth pathways. Western Europe's mature healthcare systems continue to adopt incremental device innovations, whereas emerging markets in the Middle East are investing in center-of-excellence programs to establish surgical hubs of regional importance. Across Africa, capacity constraints and workforce training gaps present challenges, yet targeted public-private collaborations are beginning to introduce minimally invasive techniques in tertiary care facilities. In the Asia-Pacific region, expanding healthcare budgets, government initiatives to modernize public hospitals, and rising medical tourism converge to create a fertile environment for new equipment launches and localized manufacturing ventures.

Examining Leading Industry Players' Strategic Initiatives, Technological Collaborations, and Competitive Positioning in Minimally Invasive Surgery

Leading players in the minimally invasive surgery domain have pursued multifaceted strategies to reinforce their market positioning and accelerate innovation. Global device manufacturers have launched cross-platform integrations that combine imaging, energy delivery, and navigation capabilities, aiming to deliver comprehensive procedural suites that enhance surgeon workflow. Strategic acquisitions of robotics specialists and energy device innovators have bolstered their product roadmaps, while collaborative partnerships with academic centers facilitate early-stage validation and surgeon training programs.

At the same time, pure-play robotics developers continue to differentiate through next-generation platforms that prioritize modular design and artificial intelligence-driven assistance. By forging alliances with software firms and cloud-based analytics providers, these emerging entrants are redefining the standard for intraoperative decision support. Meanwhile, specialty companies focused on advanced optics and ergonomic instrument handles leverage niche expertise to influence broader system designs. Collectively, these competitive moves underscore a market characterized by both consolidation among incumbents and disruptive leaps from agile innovators.

Delivering Actionable Recommendations for Industry Leaders to Navigate Regulatory Challenges, Accelerate Innovation, and Optimize MIS Market Entry

To navigate the evolving landscape, industry leaders should prioritize regulatory engagement that expedites approval pathways for novel devices while ensuring rigorous safety standards. Establishing dedicated teams to collaborate with regulatory bodies can streamline clinical trial design and accelerate market entry. In parallel, forging partnerships with payer organizations to develop value-based reimbursement frameworks will solidify economic incentives for minimally invasive adoption and drive broader acceptance among healthcare providers.

Investment in modular robotic architectures that accommodate both multiarm and singlearm applications can unlock new revenue streams across diverse care settings. By offering scalable platforms, manufacturers can tailor solutions to the procedural requirements of ambulatory surgery centers, community hospitals, and tertiary care facilities. Moreover, integrating telecollaboration and remote monitoring functionalities will support surgeon training, postoperative follow-up, and cross-institutional best practice sharing.

Supply chain resilience must also be addressed through strategic sourcing and nearshoring initiatives that mitigate tariff-induced volatility. Building local manufacturing partnerships and diversifying component suppliers will enhance cost stability and ensure uninterrupted access to critical instrumentation. Finally, leveraging real-world evidence and data analytics to demonstrate clinical outcomes and cost savings will strengthen market positioning and facilitate payor negotiations, paving the way for sustained growth in the minimally invasive surgery arena.

Explaining the Rigorous Multi-Source Research Methodology Employed to Ensure Comprehensive Analysis and Credible Insights in MIS Reporting

This report synthesizes insights drawn from a rigorous multi-tiered research methodology designed to capture both macro-level trends and granular sector nuances. Primary research encompassed in-depth interviews with key opinion leaders, including end users in ambulatory surgery centers and hospitals, procurement specialists, and clinical thought leaders. These firsthand perspectives provided critical validation for emerging device preferences and procedural workflows.

Complementing this, secondary research involved systematic examination of published literature, regulatory filings, and white papers on surgical robotics, energy devices, and advanced imaging systems. Proprietary databases served to cross-reference OEM announcements, partnership disclosures, and clinical trial registries. The resulting analysis was then triangulated through expert workshops and peer reviews to ensure robustness and impartiality, yielding a comprehensive framework that supports strategic decision making.

Drawing Comprehensive Conclusions that Integrate Key Trends, Strategic Imperatives, and Future Outlooks for Minimally Invasive Surgical Practices

In conclusion, the minimally invasive surgery sector stands at the intersection of technological ingenuity and shifting healthcare imperatives. Device innovation across endoscopes, energy delivery systems, laparoscopic instruments, and video equipment continues to redefine procedural possibilities, while robotic assistance expands ergonomic and precision frontiers. Simultaneously, tariff pressures and regional disparities underscore the need for proactive supply chain strategies and localized market approaches.

Looking ahead, the successful deployment of minimally invasive solutions will hinge on cross-industry collaboration, regulatory foresight, and data-driven value demonstration. By aligning product development with clinician needs, forging payer partnerships, and embracing modular, interoperable platforms, stakeholders can navigate complexity and capture long-term growth opportunities. This executive summary provides a strategic blueprint for informed decision making in a rapidly evolving surgical environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Minimally Invasive Surgery Market, by Device Type

  • 8.1. Endoscopes
  • 8.2. Energy Devices
  • 8.3. Laparoscopic Instruments
    • 8.3.1. Dissectors
    • 8.3.2. Graspers
    • 8.3.3. Retractors
    • 8.3.4. Scissors
    • 8.3.5. Trocars
  • 8.4. Video Equipment

9. Minimally Invasive Surgery Market, by Technology

  • 9.1. Manual
  • 9.2. Robotic Assisted
    • 9.2.1. Multiarm Robots
    • 9.2.2. Singlearm Robots

10. Minimally Invasive Surgery Market, by Application

  • 10.1. Cardiovascular
  • 10.2. General Surgery
  • 10.3. Gynecology
  • 10.4. Urology

11. Minimally Invasive Surgery Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
    • 11.2.1. Primary Care
    • 11.2.2. Secondary Care
    • 11.2.3. Tertiary Care

12. Minimally Invasive Surgery Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Minimally Invasive Surgery Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Minimally Invasive Surgery Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Minimally Invasive Surgery Market

16. China Minimally Invasive Surgery Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Arthrex, Inc.
  • 17.7. B. Braun SE
  • 17.8. Boston Scientific Corporation
  • 17.9. Conmed Corporation
  • 17.10. Cook Group Incorporated by The Cooper Companies, Inc.
  • 17.11. Danaher Corporation
  • 17.12. FUJIFILM Corporation
  • 17.13. GE HealthCare Technologies Inc.
  • 17.14. Getinge AB
  • 17.15. Hoya Corporation
  • 17.16. Intuitive Surgical, Inc.
  • 17.17. Johnson & Johnson Services, Inc.
  • 17.18. Karl Storz SE & Co. KG
  • 17.19. Koninklijke Philips N.V.
  • 17.20. Livanova PLC
  • 17.21. Medtronic plc
  • 17.22. Olympus Corporation
  • 17.23. Richard Wolf GmbH
  • 17.24. Siemens Healthineers AG
  • 17.25. Smith & Nephew plc
  • 17.26. Stryker Corporation
  • 17.27. Synaptive Medical Inc.
  • 17.28. Teleflex Incorporated
  • 17.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE SURGERY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DISSECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DISSECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DISSECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GRASPERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GRASPERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GRASPERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY RETRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TROCARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TROCARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TROCARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY VIDEO EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY VIDEO EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY VIDEO EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MULTIARM ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MULTIARM ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MULTIARM ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SINGLEARM ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SINGLEARM ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SINGLEARM ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY PRIMARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY PRIMARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY PRIMARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 152. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 154. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 176. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 178. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 184. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 186. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)